library.onepin.app/sam-e-s-adenosyl-methionine Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Cognitive & Mood

Cognitive & Mood Peptide Prescription drug

SAM-e (S-Adenosyl Methionine)

SAMe · S-Adenosylmethionine · AdoMet

SAM-e (S-adenosyl-L-methionine) is the universal methyl donor in human biology, participating in over 200 methyl-transfer reactions including DNA methylation, neurotransmitter synthesis (epinephrine from norepinephrine, melatonin from serotonin), phosphatidylcholine biosynthesis, creatine production, and detoxification of various xenobiotics. SAM-e is endogenously synthesized from methionine + ATP via methionine adenosyltransferase (MAT). Endogenous production declines with age, B12/folate deficiency, MTHFR polymorphisms, and chronic stress.,SAM-e is unique among supplements in that it's both a major over-the-counter mood/joint supplement (especially in the US, where it's been bestseller for 25+ years) AND a prescription pharmaceutical in many European countries (Italy, Germany, Spain) where it's licensed for depression and osteoarthritis. The US FDA has not approved SAM-e for any indication, but multiple meta-analyses confirm efficacy for major depressive disorder (effect size comparable to tricyclic antidepressants) and osteoarthritis pain (comparable to NSAIDs) without the typical side-effect profile of either drug class.,Beyond mood and joint applications, SAM-e is used in liver health (cholestasis support, NAFLD), as a methylation cycle support during MTHFR variant management, and increasingly in functional medicine protocols where methylation impairment is suspected. The compound is unstable in air/moisture - quality SAM-e supplements use enteric-coated tablets with butanedisulfonate or tosylate stabilization. Standard doses range from 200-1600mg/day, typically split into two doses (morning + lunch) to avoid late-day insomnia.

Quick Start
Route
Oral
Start low
400mg
Frequency
Twice daily
Timing
Anytime

Take 30 min before meals on empty stomach for best absorption (enteric-coated forms). Split AM + lunch dose - DO NOT take late in day (can cause insomnia/activation). Start at 200mg twice daily, titrate up over 1-2 weeks. Pair with B-complex (especially B12 + methylfolate) to support full methylation cycle and prevent SAH/homocysteine accumulation.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
400mg · Oral · Twice daily
Lowest starting point. Hold about a week to assess tolerance before stepping up.
400mg
Twice daily
Standard
Methylation & Mood
400-800 mg · Oral · Daily
human clinical trial · Mischoulon et al. 2014 (J Clin Psychiatry)
400-800 mg
Daily
01

How it works

SAM-e is the universal methyl donor produced from methionine + ATP via MAT (methionine adenosyltransferase). It donates methyl groups via methyltransferase enzymes to acceptor molecules including DNA (DNMT enzymes), histones, neurotransmitters (catechol-O-methyltransferase converts norepinephrine to epinephrine; HIOMT converts N-acetylserotonin to melatonin), creatine precursors (GAMT), and phosphatidylcholine (PEMT). After donation, SAM-e becomes SAH (S-adenosyl homocysteine) which is recycled back through the methionine cycle.,The antidepressant mechanism is multifactorial: SAM-e supports synthesis of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) via methylation-dependent enzyme regulation; it supports phosphatidylcholine production for neuronal membrane integrity; and it affects gene expression through DNA methylation in mood-relevant brain regions. Clinically, SAM-e shows antidepressant onset within 1-2 weeks (faster than SSRIs which typically take 4-6 weeks).,The osteoarthritis mechanism involves stimulation of glycosaminoglycan and proteoglycan synthesis in articular cartilage chondrocytes - mechanistically distinct from NSAID anti-inflammatory action. Animal studies confirm SAM-e increases proteoglycan content in articular cartilage. Joint pain reduction effect size is similar to NSAIDs but without the GI/cardiovascular risk profile. The liver-protective effects involve restoration of hepatic glutathione via methylation-dependent cysteine production and reduced oxidative stress in hepatocytes.

SAM-e is the universal methyl donor produced from methionine + ATP via MAT (methionine adenosyltransferase). It donates methyl groups via methyltransferase enzymes to acceptor molecules including DNA (DNMT enzymes), histones, neurotransmitters (catechol-O-methyltransferase converts norepinephrine to epinephrine; HIOMT converts N-acetylserotonin to melatonin), creatine precursors (GAMT), and phosphatidylcholine (PEMT). After donation, SAM-e becomes SAH (S-adenosyl homocysteine) which is recycled back through the methionine cycle.,The antidepressant mechanism is multifactorial: SAM-e supports synthesis of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) via methylation-dependent enzyme regulation; it supports phosphatidylcholine production for neuronal membrane integrity; and it affects gene expression through DNA methylation in mood-relevant brain regions. Clinically, SAM-e shows antidepressant onset within 1-2 weeks (faster than SSRIs which typically take 4-6 weeks).,The osteoarthritis mechanism involves stimulation of glycosaminoglycan and proteoglycan synthesis in articular cartilage chondrocytes - mechanistically distinct from NSAID anti-inflammatory action. Animal studies confirm SAM-e increases proteoglycan content in articular cartilage. Joint pain reduction effect size is similar to NSAIDs but without the GI/cardiovascular risk profile. The liver-protective effects involve restoration of hepatic glutathione via methylation-dependent cysteine production and reduced oxidative stress in hepatocytes.

02

What to expect

Early
Days 1–7

Days 3-14: Mood improvements begin in many users.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent
2004S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms · Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW, BMC Musculoskeletal Disorders ↗peer reviewed
2016S-adenosyl methionine for depression · Galizia I, Oldani L, Macritchie K, Amari E, Dougall D, Jones TN, Lam RW, Massei GJ, Yatham LN, Young AH, Cochrane Database of Systematic Reviews ↗review
2002S-adenosyl methionine in osteoarthritis: a review of the clinical evidence · Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM, Journal of Family Practice ↗review
2012S-adenosylmethionine: from the bench to the bedside - molecular basis of a pleiotropic molecule · Lu SC, Mato JM, American Journal of Clinical Nutrition ↗review
04

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

Omega-3 Fatty AcidsAnti-inflammatory complement to SAM-e's antidepressant and joint effects.
Vitamin DBoth support mood and joint function through different mechanisms.
Methylfolate (5-MTHF)Methylfolate generates SAM-e endogenously via methionine cycle; supplementing both supports methylation reserve.
Methylcobalamin (B12)B12 is cofactor for methionine synthase, the enzyme that recycles SAH back to methionine. Essential pairing for chronic SAM-e use.

Keep separate

MAOI Antidepressants (Phenelzine, Tranylcypromine, Selegiline)SAM-e supports monoamine synthesis; combined with MAOIs increases serotonin syndrome risk significantly. Avoid combination.
SSRIs (Fluoxetine, Sertraline, etc.)Theoretical serotonin syndrome risk. Most clinical experience suggests low risk at supplement doses, but monitor for symptoms (agitation, tremor, hyperthermia, restlessness).
Levodopa (Parkinson's disease)SAM-e methylation can reduce levodopa effectiveness via increased COMT-mediated levodopa metabolism. May worsen Parkinson's symptoms.
Bipolar DisorderSAM-e can trigger mania or hypomania in bipolar individuals (especially type I). Avoid in bipolar or use only under psychiatric supervision.
05

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
~100 minutes (plasma)
Peak · Tmax
~3-5 hours (enteric-coated oral)
Elimination
~24 hours
Activity
Pharmacological effects sustained with twice-daily dosing. Antidepressant effects build over 1-4 weeks.

Storage. Store enteric-coated tablets in original blister pack at room temperature (20-25C) in cool, dry place. SAM-e is unstable in air and moisture - DO NOT remove tablets from blister pack until use. Refrigeration extends shelf life. Bulk SAM-e powder degrades quickly and is not recommended.

06

Regulatory status

Classified as a dietary supplement in the US (no FDA pre-approval). Available widely over the counter. Prescription pharmaceutical in Italy, Germany, Spain, and other EU countries (licensed for depression and osteoarthritis). Major branded products include Nature Made SAM-e, Doctor's Best SAM-e (with butanedisulfonate stabilization).

Put it to work

Calculate, log & track

Open SAM-e (S-Adenosyl Methionine) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open SAM-e (S-Adenosyl Methionine) in the app →

Go deeper

The guide & community

The complete SAM-e (S-Adenosyl Methionine) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community